#United States #financial results #Waters Corporation #Milford, Massachusetts #Q1 2025

Waters Corporation Reports Outstanding First Quarter 2025 Results

In its recent announcement, Waters Corporation (NYSE: WAT) showcased robust financial results for the first quarter of 2025. With sales reaching $662 million, this figure not only exceeded expectations but also marked a 4% increase compared to $637 million in the same period last year. More impressively, a 7% growth was recorded when accounting for constant currency, reflecting solid performance amid varied economic conditions.

The quarter's success can predominantly be attributed to an 11% growth in the instrument segment, showcasing the company's strength in the pharmaceutical and industrial markets. According to Dr. Udit Batra, President and CEO of Waters Corporation, the results were driven by significant demand for innovative products in their portfolio, reinforcing the company's standing despite a fluctuating external environment.

Key Financial Highlights

• - Sales: $662 million (4% increase YoY)
• - GAAP Earnings Per Share (EPS): $2.03 compared to $1.72 in Q1 2024
• - Non-GAAP EPS: $2.25 (up 2% YoY, adjusting for foreign currency effects)

"Thanks to the commitment and hard work of our teams, we have maintained robust business momentum despite a rapidly shifting economic environment," Dr. Batra stated, adding that the impressive results prompted the company to raise its full-year guidance for 2025.

Revised Guidance for Full-Year 2025

In light of the strong first quarter performance, Waters Corporation has increased its full-year constant currency sales growth guidance to between 5.0% and 7.0%. The reported sales growth guidance has been adjusted to 4.0% to 6.0%. Furthermore, the non-GAAP EPS guidance has also been raised to between $12.75 and $13.05, representing a healthy year-over-year growth ranging from 8% to 10%, and 10% to 12% on a constant currency basis.

Looking Forward

For the second quarter of 2025, Waters Corporation anticipates a constant currency sales growth of 5.0% to 7.0%, with a reported sales growth projected in the 4.0% to 6.0% range. The non-GAAP EPS for this period is expected to fall between $2.88 and $2.98, which translates to a year-over-year growth of 10% to 13%.

Dr. Batra emphasized the company's commitment to operational excellence and innovation, positioning Waters favorably to counteract the impact of recent tariffs and policy changes.

With over 65 years of experience, Waters Corporation continues to be a leader in analytical instruments and software solutions, serving industries ranging from pharmaceuticals to environmental sciences across the globe. As they navigate the complexities of a dynamic marketplace, their focus remains on leveraging operational efficiencies to enhance profitability and growth.

For more detailed results and to listen to the live Q1 results conference call, visit Waters Corporation Investor Relations.

Conclusion

Waters Corporation’s strong start to 2025 underscores its strategic approach to innovation and market adaptation. As the company drives forward, stakeholders can be optimistic about its continued growth trajectory and the role it will play in advancing scientific progress and product sustainability. Staying tuned to their next moves will be essential for investors and industry watchers alike.